These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35778954)

  • 1. LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
    Liu F; Cao L; Zhang Y; Xia X; Ji Y
    J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
    Yi D; Zhang D; He J
    Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
    Ding H; Cui L; Wang C
    Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
    Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
    Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
    Wu K; Li L; Li L; Wang D
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of SBF2-AS1 inhibits cell growth and invasion by sponging microRNA-338-3p in serous ovarian carcinoma.
    Luan AA; Hou LL; Zhang FY
    Kaohsiung J Med Sci; 2022 Apr; 38(4):302-311. PubMed ID: 34850542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
    Xu F; Li H; Hu C
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
    Yuan S; Bi J; Zhang Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):1-12. PubMed ID: 36734853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.